Radiopharm Theranostics (RAD:AU) has announced Acceleration of RAD204 Phase 1 dose escalation trial Download the PDF here. This post appeared first on investingnews.com Prev Post Multiple New Multi-Commodity Targets May 12, 2025 Next Post Walgreens doubles down on prescription-filling robots to cut costs, free up pharmacists amid turnaround May 13, 2025 Related Posts CleanTech Lithium November 3, 2025 Locksley Resources LimitedReceives up to US$191M Potential Support from EXIM Bank November 3, 2025 RUA GOLD Engages ICP Securities Inc. for Automated Market Making Services November 3, 2025